THE INACTIVATION OF THE GENE OF ARGININE DEIMINAZE OF STREPTOCOCCI REDUCES THE DEGREE OF THEIR ANTINEOPLASTIC ACTIVITY IN THE COURSE OF IN VITRO AND IN VIVO EXPERIMENTS
- Authors: Suvorova MA1, Kramskaja TA1, Karaseva AB1, Mukhin VN1, Ermolenko EI1,2, Suvorov AN1,2
-
Affiliations:
- Institute of Experimental Medicine
- St. Petersburg State University
- Issue: Vol 17, No 1 (2017)
- Pages: 96-101
- Section: Articles
- URL: https://journals.eco-vector.com/MAJ/article/view/9422
- DOI: https://doi.org/10.17816/MAJ17196-101
- ID: 9422
Cite item
Abstract
Keywords
Full Text
About the authors
M A Suvorova
Institute of Experimental Medicine
T A Kramskaja
Institute of Experimental Medicine
A B Karaseva
Institute of Experimental Medicine
V N Mukhin
Institute of Experimental Medicine
E I Ermolenko
Institute of Experimental Medicine; St. Petersburg State University
A N Suvorov
Institute of Experimental Medicine; St. Petersburg State University
References
- Stewart B.W., Bray1 F., Forman D., Ohgaki H., Straif1 K., Ullrich A., Wild1 C. P. Cancer prevention as part of precision medicine: ‘plenty to be done’ // Carcinogenesis. 2016. Vol. 1. P. 2-9.
- Jessy T. Immunity over inability: the spontaneous regression of cancer // J. Nat Sci Biol Med. 2011. Vol. 2. P. 43-49.
- Nair N., Kasai T., Seno M. Bacteria: Prospective Savior in Battle against Cancer // Anticancer Res. 2014. Vol. 34, No 11. P. 6289-6296.
- Liu S., Xu X., Zeng X., Li L., Chen Q., Li J. Tumor-targeting bacterial therapy: A potential treatment for oral cancer // Oncology Letters. 2014. Vol. 6. P. 2359-2366.
- Maletzki C., Gock M., Klier U., Klar E., Linnebacher M. Bacteriolytic therapy of experimental pancreatic carcinoma // World J. Gastroenterol. 2010. Vol. 16, № 28. P. 3546-3552.
- Chen I.J., Yen C.F., Lin K.J., Lee C.L., Soong Y.K., Lai C.H., Lin C.T. Vaccination with OK-432 followed by TC-1 tumor lysate leads to significant antitumor effects // Reprod Sci. 2011. Vol. 7. P. 687-694.
- Maletzki C1., Emmrich J. Inflammation and immunity in the tumor environment // Dig Dis. - 2010. Vol. 28. P. 574-578.
- Hirayama M., Nishikawa H., Nagata Y., Tsuji T., Kato T., Kageyama S., Ueda S., Sugiyama D., Hori S., Sakaguchi S., Ritter G, Old LJ, Gnjatic S, Shiku H. Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes // Eur J. Immunol. - 2013. Vol. 4. P. 989-1000.
- Lanuza G.A1., Bañón N.R., Llorca C.A., Delgado N.C. Unsuccessful treatment with OK-432 picibanil for orbital lymphangioma // Arch. Soc. Esp. Oftalmol. 2012. Vol. 1. P. 17-19.
- Kanaoka M., Kawanaka C., Negoro T., Fukita Y., Kiyoshi Т., Agui H. Cloning and Expression of the Anti tumor Glycoprotein Gene of Streptococcus pyogenes Su in Escherichia coli Masaharu Kanaoka // Agric. Biol. Chem. 1987. Vol. 10. P. 2641-2648.
- Dillon B.J., Prieto V.G., Curley SA, Ensor C.M., Holtsberg F.W., Bomalaski J.S. et al. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation // Cancer. 2004. Vol. 7. P. 826-833.
- Suvorov A.N., Kok J., Venema G. Transformation of group A streptococci by electroporation // FEMS Microbiol. Lett. 1988. Vol. 56. P. 95-100.
- Cusumano Z.T., Caparon M.G. Citrulline Protects Streptococcus pyogenes from Acid Stress Using the Arginine Deiminase Pathway and the F1Fo-ATPase // J. Bacteriol. 2015. Vol. 197, No 7. P. 1288-1296.
- Cunin R. Glansdorff N., Piérard A., Stalon V. Biosynthesis and metabolism of arginine in bacteria // Microbiol Rev. 1986. Vol. 50, No 3. P. 314-352.
- Feun L., You M., Wu C.J., Kuo M.T., Wangpaichitr M., Spector S., Savara J.N. Arginine Deprivation as a Targeted Therapy for Cancer // Current Pharmaceutical Design. 2008. Vol. 14, № 11. P. 1049-1057.
- Ni Y., Schwaneberg U., Sun Z.-H. Arginine deiminase, a potential anti-tumor drug // Cancer Letters. 2008. Vol. 261, No 1. P. 1-11.
- Synakiewicz A., Stachowicz-Stencel T., Adamkiewicz-Drozynska E. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials // Expert Opinion on Investigational Drugs. 2014. Vol. 23, No 11. P. 1517-1529.
- Starikova E.A. et al. Biochemical and biological activity of arginine deiminase from Streptococcus pyogenes M22 // Biochem. Cell Biol. 2015. Vol. 94, No 2. P. 129-137.
- Старикова Э.А., Карасева А.Б., Бурова Л.А., Суворов А.Н., Соколов А.В., Васильев В.Б., Фрейдлин И.С. Роль аргининдеиминазы Sterprococcus pyogenes М49-16 в ингибиции пролифирации эндотелиальных клеток человека линии EA.hy926 // Медицинская иммунология. 2016. Т. 18 № 6. P. 559-566. [Starikova E., Karaseva A., Burova L., Suvorov A., Sokolov A., Vasilyev V., Freidlin J., Medical Immunology, 2016, vol. 18, No 6, рр. 559-566.].
- Fiedler T., Strauss M., Hering S., Redanz U., William D., Rosche Y., Classen CF., Kreikemeyer B., Linnebacher M., Maletzki C. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo // Cancer Biol Ther. 2015. Vol. 7. P. 1047-1055.
- Yang W.S., Park S.O., Yoon A.R., Yoo J.Y., Kim M.K., Yun C.O., Kim C.W. Suicide cancer gene therapy using pore-forming toxin, streptolysin // Mol. Cancer Ther. 2006. Vol. 6. P. 1610-1619.